Form 4: American Vanguard CHRO Receives Stock Option Grant

American Vanguard Corporation CHRO Shirin Khosravi was granted 20,000 incentive stock options on June 4, 2026.

Summary

• Shirin Khosravi, Chief Human Resources Officer (CHRO) of American Vanguard Corp, received a grant of 20,000 incentive stock options.
• The options have an exercise price of $2.51 per share.
• The grant date is June 4, 2026, with an expiration date of June 4, 2036.
• The options vest in their entirety on the third anniversary of the grant date (June 4, 2029).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation with no immediate impact on company operations or financial health.

Positives

• Alignment of executive interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the exercise of these options.

Risks

• The value of the options is dependent on the future market performance of American Vanguard common stock.

Future Outlook

The options vest in three years, indicating a long-term retention incentive for the CHRO.

Management Comments

• The filing contains no narrative management commentary beyond the required disclosure of the transaction.

Industry Context

StockSavvy.ai notes that equity grants to key executives are standard corporate governance practices intended to align management incentives with long-term company performance.

Comparison to Industry Standards

• The use of three-year cliff vesting for incentive stock options is consistent with standard executive compensation practices in the mid-cap industrial and chemical sectors.

Stakeholder Impact

• Minor potential dilution for existing shareholders if options are exercised in the future.

Next Steps

• Vesting of options on June 4, 2029.

Key Dates

Keywords

American Vanguard, AVD, Form 4, Insider Trading, Stock Options, Executive Compensation